
The episode explores the modifiability of chronic diseases and cognitive decline through functional and precision medicine.
What if chronic disease, cognitive decline, and even trauma were not fixed conditions—but modifiable biological states? In this Functional Forum episode, James Maskell and Matt Wiggins bring together leading clinicians and researchers to explore the frontiers of precision and functional medicine. They discuss SUPAR, a powerful biomarker for systemic inflammation that could reshape early disease detection. The conversation then turns to a groundbreaking cognitive decline trial showing major improvements in patients treated with functional medicine protocols compared to standard care. The episode also explores the biology of loneliness and the "cell danger response," the reversibility of trauma through epigenetic mechanisms and psychedelic-assisted therapy, and emerging ideas about measuring masculinity as a clinical health indicator. Together, these insights point toward a future where chronic disease may be detected earlier, treated systemically, and in some cases reversed. - - - - - About the Guests: This episode features multiple leading voices from the Functional Forum community, including clinicians and researchers in functional and precision medicine: Matt Wiggins – Health…
Host: James Maskell
Guests: Matt Wiggins, Dr. Kat Toups, Dr. Molly Maloof
Organizations: Functional Forum
Products: SUPAR
Explore listener stats, chart rankings, contacts and more on the Evolution of Medicine Podcast podcast page.